AGAMREE (vamorolone) has been recommended for use in the National Health Service (NHS) in England, Wales, and Northern Ireland for the treatment of Duchenne...
The medication vamorolone, also marketed under the brand name Agamree, has been approved by the Scottish Medicines Consortium (SMC) as a therapy option for...
Let's learn together the answers to the frequently asked questions by Duchenne muscular dystrophy (DMD) patients about Eteplirsen (Exondys 51), which was approved by...
A genetic condition known as Duchenne muscular dystrophy (DMD) results in gradual muscle weakening. Boys are more likely to have DMD, with symptoms first...